GL1X · GenesisL1 explorer

Research workbench

Crystal structure of topoisomerase pare inhibitor

Analyse Crystal structure of topoisomerase pare inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5BOC
Type
protein
Length
192 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
DNA topoisomerase 4 subunit B
EC
5.99.1.3
UniProt
Q8DQB5
Ligands
TSJ
Pockets
1 · best druggability 0.52

Structure

x-ray diffraction · 1 distinct chain · 31% helix, 30% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADNA topoisomerase 4 subunit B (EC 5.99.1.3)protein19231% helix, 30% strandQ8DQB5

Ligands and binding sites

  • TSJ · 3-methyl-4-({3-[3-methyl-5-(trifluoromethyl)phenyl]-1H-pyrazol-5-yl}carbamoyl)benzoic acid · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11150.520.8224TSJ

Compared structures

  • 5BOC · Crystal structure of topoisomerase ParE inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.